Novartis competitors and similar companiesClear all

Novartis's competitors and similar companies include Merck Group, Bausch + Lomb, Immunomedics, Gilead Sciences, Sanofi, AstraZeneca, Johnson & Johnson, Bayer and Pfizer.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Merck Group
Merck Group
Merck Group is a pharmaceutical, chemical, and life sciences company.
Bausch + Lomb
Bausch + Lomb
Bausch + Lomb is a company that develops, manufactures, and markets healthcare products.
Immunomedics
Immunomedics
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson is a global holding company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date
Founding Date
1996
Founding Date
1668
Founding Date
1853
Founding Date
1982
Founding Date
1987
Founding Date
2004
Founding Date
1999
Founding Date
1886
Founding Date
1863
Founding Date
1849
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Darmstadt, DE HQ
Hydra, DZ
Buenos Aires, AR
Bayswater, AU
Macquarie Park, AU
Wien, AT
Manama, BH
see more
Locations
Vaughan, CA HQ
Buenos Aires, AR
Vienna, AT
Minsk, BY
Mechelen, BE
Porto Alegre, BR
São Paulo, BR
see more
Locations
Morris Plains, US HQ
Locations
Foster City, US HQ
Buenos Aires, AR
Melbourne, AU
Wien, AT
Machelen, BE
São Paulo, BR
Edmonton, CA
see more
Locations
Paris, FR HQ
Hydra, DZ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
see more
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
New Brunswick, US HQ
Buenos Aires, AR
Chippendale, AU
Wien, AT
Minsk, BY
Beerse, BE
Brussel, BE
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Footscray, AU
Mulgrave, AU
Sydney, AU
see more
Employees
Employees
104,3231% decrease
Employees
59,3086% decrease
Employees
12,50036% decrease
Employees
1384% decrease
Employees
14,4006% increase
Employees
95,4424% decrease
Employees
76,1008% increase
Employees
141,7005% increase
Employees
101,9141% increase
Employees
79,0001% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
81.4 b
Valuation ($)
5.3 b
Valuation ($)
N/A
Valuation ($)
110.3 b
Valuation ($)
116.2 b
Valuation ($)
212.9 b
Valuation ($)
467.3 b
Valuation ($)
56.8 b
Valuation ($)
286.7 b
Twitter followers
Twitter followers
302.4 k
Twitter followers
24.3 k
Twitter followers
17.7 k
Twitter followers
579
Twitter followers
72.7 k
Twitter followers
150.3 k
Twitter followers
303.1 k
Twitter followers
249.5 k
Twitter followers
184.6 k
Twitter followers
32 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
33
Number of tweets (last 30 days)
31
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
21
Number of tweets (last 30 days)
36
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
53
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
7.3
Average likes per tweet (last 30 days)
0.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12.9
Average likes per tweet (last 30 days)
14.4
Average likes per tweet (last 30 days)
11.9
Average likes per tweet (last 30 days)
7
Average likes per tweet (last 30 days)
11.5
Average likes per tweet (last 30 days)
17.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
35.48%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
80.95%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
54.55%
Percentage of tweets with engagement (last 30 days)
49.06%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
129099
Alexa Website Rank
70623
Alexa Website Rank
276147
Alexa Website Rank
N/A
Alexa Website Rank
187202
Alexa Website Rank
155495
Alexa Website Rank
71159
Alexa Website Rank
17146
Alexa Website Rank
105500
Alexa Website Rank
33980
Employee Rating
Employee Rating
4.2
Employee Rating
4.1
Employee Rating
3.9
Employee Rating
2.9
Employee Rating
3.8
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
4.2
Employee Rating
4.3
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
€19.7b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$295k (FY, 2019)
Revenue (est.)
$27.3b (FY, 2021)
Revenue (est.)
€37.8b (FY, 2021)
Revenue (est.)
$37.4b (FY, 2021)
Revenue (est.)
$93.8b (FY, 2021)
Revenue (est.)
€44.1b (FY, 2021)
Revenue (est.)
$81.3b (FY, 2021)
Cost of goods
Cost of goods
$9.7b (FY, 2021)
Cost of goods
€7.4b (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$6.6b (FY, 2021)
Cost of goods
(€10.7b) (FY, 2021)
Cost of goods
$5.9b (FY, 2021)
Cost of goods
$29.9b (FY, 2021)
Cost of goods
(€11.7b) (FY, 2021)
Cost of goods
$30.8b (FY, 2021)
Gross profit
Gross profit
$45.1b (FY, 2021)
Gross profit
€12.3b (FY, 2021)
Gross profit
N/A
Gross profit
$295k (FY, 2019)
Gross profit
$20.7b (FY, 2021)
Gross profit
€28.9b (FY, 2021)
Gross profit
$32b (FY, 2021)
Gross profit
$63.9b (FY, 2021)
Gross profit
€33.6b (FY, 2021)
Gross profit
$50.5b (FY, 2021)
Net income
Net income
$24b (FY, 2021)
Net income
€3.1b (FY, 2021)
Net income
N/A
Net income
($357.3m) (FY, 2019)
Net income
$6.2b (FY, 2021)
Net income
€6.2b (FY, 2021)
Net income
$115m (FY, 2021)
Net income
$20.9b (FY, 2021)
Net income
€1b (FY, 2021)
Net income
$22b (FY, 2021)

Operating

Countries
Countries
N/A
Countries
66 (FY, 2021)
Countries
100 (Nov, 2020)
Countries
N/A
Countries
35 (FY, 2021)
Countries
N/A
Countries
130 (FY, 2021)
Countries
N/A
Countries
83 (FY, 2021)
Countries
125 (FY, 2021)
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
7 (FY, 2019)
Phase I Trials Products (Oncology)
9 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2021)
Phase II Trials Products (Oncology)
12 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
54 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
9 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
27 (FY, 2021)
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
27 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
4 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Products
Products
N/A
Products
300 k (FY, 2021)
Products
N/A
Products
N/A
Products
21 (FY, 2021)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
177 (FY, 2021)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Registration Phase Products
Registration Phase Products
8 (FY, 2021)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
10 (FY, 2021)
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
68 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A
Suppliers
93.8 k (FY, 2021)
Suppliers
N/A

Funding

Total funding raised
Total funding raised
$ 6.5m
Total funding raised
$ 121m
Total funding raised
N/A
Total funding raised
$ 30m
Total funding raised
N/A
Total funding raised
$ 310m
Total funding raised
$ 1b
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Merck Group
HQ
Darmstadt, DE
Employees
59,308↓ 6% decrease

Merck Group is a pharmaceutical, chemical, and life sciences company.

View company
Bausch + Lomb
HQ
Vaughan, CA
Employees
12,500↓ 36% decrease

Bausch + Lomb is a company that develops, manufactures, and markets healthcare products.

View company
Immunomedics
HQ
Morris Plains, US

Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.

View company
Gilead Sciences
HQ
Foster City, US
Employees
14,400↑ 6% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.

View company